Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TH-302 in Combination With Bevacizumab for Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02342379
Recruitment Status : Active, not recruiting
First Posted : January 19, 2015
Last Update Posted : October 26, 2018
Sponsor:
Information provided by (Responsible Party):
Andrew Brenner, The University of Texas Health Science Center at San Antonio

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : July 2019